These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13608345)

  • 1. Circulating fibrinolysin in carcinoma of the prostate.
    BALFOUR J
    Can J Surg; 1959 Jan; 2(2):138-41. PubMed ID: 13608345
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating fibrinolysin in a case of prostatic carcinoma with bony metastases.
    BERGEN S; SCHILLING FJ
    Ann Intern Med; 1958 Feb; 48(2):389-98. PubMed ID: 13509544
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolysis in patients with metastatic carcinoma of the prostate gland.
    DOLAZ EJ; DOLEHIDE RA; FRIEDMAN IA
    Ill Med J; 1955 Mar; 107(3):142-4. PubMed ID: 14353517
    [No Abstract]   [Full Text] [Related]  

  • 4. STUDIES OF FIBRINOLYSIS AND ACID PHOSPHATASE IN CANCER OF THE PROSTATE.
    TAGNON HJ; STEENS-LIEVENS A
    Natl Cancer Inst Monogr; 1963 Oct; 12():297-305. PubMed ID: 14073000
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some unusual aspects of fibrinolysis in the diagnosis of prostatic carcinoma].
    MAIRANO C; RIGOTTI E
    Minerva Urol; 1960; 12():148-51. PubMed ID: 13765499
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostatic enzymes and abnormal bleeding.
    SCOTT EV
    Trans Southeast Sect Am Urol Assoc; 1955; (19th Meeting):50-5; discussion, 56-7. PubMed ID: 13274457
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metastatic prostatic cancer with hemorrhagic diathesis due to fibrinolysis; case report].
    RASMUSSEN J; SCHWARTZ M
    Ugeskr Laeger; 1957 Aug; 119(34):1086-90. PubMed ID: 13468146
    [No Abstract]   [Full Text] [Related]  

  • 8. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilemmas in the treatment of urothelial cancers of the prostate.
    Walsh DL; Chang SS
    Urol Oncol; 2009; 27(4):352-7. PubMed ID: 18439852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
    Zheng XY; Ding W; Xie LP; Chen ZD
    Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of inflammation and infection in the pathogenesis of prostate carcinoma.
    Wagenlehner FM; Elkahwaji JE; Algaba F; Bjerklund-Johansen T; Naber KG; Hartung R; Weidner W
    BJU Int; 2007 Oct; 100(4):733-7. PubMed ID: 17662075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of fat emulsion intravenously in the control of hemorrhage due to thrombolysin activity.
    BIGGS AW; DOUGDALE M; RAINES SL; NEFT LG
    South Med J; 1961 Nov; 54():1252-4. PubMed ID: 13869122
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of loss of heterozygosity on chromosome 8 in human prostate carcinoma and high grade prostatic intraepithelial neoplasia].
    Wang Z; Lai FM
    Zhonghua Nan Ke Xue; 2004 Jan; 10(1):26-8, 31. PubMed ID: 14979203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
    Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
    Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.
    Punglia RS; D'Amico AV; Catalona WJ; Roehl KA; Kuntz KM
    Cancer; 2006 Apr; 106(7):1507-13. PubMed ID: 16518812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma.
    Freeman VL; Meydani M; Hur K; Flanigan RC
    Cancer; 2004 Dec; 101(12):2744-54. PubMed ID: 15495177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden.
    Chokkalingam AP; Nyrén O; Johansson JE; Gridley G; McLaughlin JK; Adami HO; Hsing AW
    Cancer; 2003 Oct; 98(8):1727-34. PubMed ID: 14534890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.